CV Sciences (CVSI) Income from Continuing Operations (2011 - 2026)

CV Sciences' (CVSI) quarterly Income from Continuing Operations came in at 643000.0 in Q1 2026, down 489.91% year-on-year from 164910.59 in Q1 2025, and down 269.66% quarter-over-quarter from 379000.0 in Q4 2025.

CV Sciences (CVSI) Income from Continuing Operations (2011 - 2026) Analysis & Trends

CV Sciences has disclosed Income from Continuing Operations across 16 years of filings, most recently posting 643000.0 for Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 643000.0, down 489.91% year-over-year; the trailing twelve-month figure through Mar 2026 was 907000.0 (up 51.63% YoY), and the FY2025 annual result was 373000.0, up 84.42% from the prior year.
  • Income from Continuing Operations came in at 643000.0 for Q1 2026 at CV Sciences, down from 379000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 5706000.0 in Q1 2023 to a low of 3983000.0 in Q4 2023.
  • The 5-year median for Income from Continuing Operations is 628000.0 (2024), against an average of 643176.47.
  • Across the five-year window, Income from Continuing Operations tumbled 2477.5% in 2022 and soared 476.63% in 2023, its largest moves.
  • CV Sciences' Income from Continuing Operations stood at 2313000.0 in 2022, then plunged by 72.2% to 3983000.0 in 2023, then jumped by 81.77% to 726000.0 in 2024, then soared by 152.2% to 379000.0 in 2025, then slumped by 269.66% to 643000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 643000.0 (Q1 2026), 379000.0 (Q4 2025), and 382000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 370.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -92.12 Mn
10 CV Sciences - - 1.56 Mn -643,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -643,000.00
Dec 31, 2025 379,000.00
Sep 30, 2025 -382,000.00
Jun 30, 2025 -261,000.00
Mar 31, 2025 -109,000.00
Dec 31, 2024 -726,000.00
Sep 30, 2024 -456,000.00
Jun 30, 2024 -584,000.00
Mar 31, 2024 -628,000.00
Dec 31, 2023 -3.98 Mn
Sep 30, 2023 -447,000.00
Jun 30, 2023 -1.29 Mn
Mar 31, 2023 5.71 Mn
Dec 31, 2022 -2.31 Mn
Sep 30, 2022 -1.03 Mn
Jun 30, 2022 -2.65 Mn
Mar 31, 2022 -1.52 Mn
Dec 31, 2021 -8.86 Mn
Sep 30, 2021 -40,000.00
Jun 30, 2021 -3.53 Mn